Evelyn Partners Investment Management’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.49M Sell
25,372
-1,905
-7% -$566K 0.2% 66
2025
Q4
$7.45M Sell
27,277
-248
-0.9% -$67.4K 0.21% 68
2025
Q3
$7.44M Buy
27,525
+120
+0.4% +$32.6K 0.21% 67
2025
Q2
$7.55M Sell
27,405
-3,258
-11% -$886K 0.23% 64
2025
Q1
$8.13M Buy
30,663
+1,649
+6% +$407K 0.27% 64
2024
Q4
$6.74M Buy
+29,014
New +$6.67M 0.22% 67

Other funds holding CME

Evelyn Partners Investment Management's CME Position: Q1 2026 in Review

Evelyn Partners Investment Management reduced its CME Group (CME) stake by 7% in Q1 2026, selling an estimated $566K and leaving 25,372 shares worth $7.49M. The position accounts for 0.2% of the portfolio, ranked #66.

Evelyn Partners Investment Management first reported a position in CME in Q4 2024 and has held it in 6 quarters since. The position peaked at $8.13M in Q1 2025. 1,791 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Evelyn Partners Investment Management held 25,372 shares of CME Group worth $7.49M as of Q1 2026.
  • Evelyn Partners Investment Management sold 1,905 CME Group shares in Q1 2026, an estimated $566K.
  • CME Group made up 0.2% of Evelyn Partners Investment Management's portfolio in Q1 2026, its #66 holding.
  • Evelyn Partners Investment Management first reported a position in CME Group in Q4 2024 and has held it in 6 quarters since.
  • Evelyn Partners Investment Management's CME Group position peaked at $8.13M in Q1 2025.
  • 1,791 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Evelyn Partners Investment Management's 13F filing for Q1 2026, filed 15 May 2026.